What is the recommended dose of insulin (intravenous/ subcutaneous injection of insulin) for a patient with diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Insulin Dosing

For type 1 diabetes, start with 0.5 units/kg/day total daily dose, with half as basal insulin and half as prandial insulin; for type 2 diabetes, initiate basal insulin at 10 units once daily or 0.1-0.2 units/kg/day, then titrate by 2-4 units every 3 days until fasting glucose reaches 80-130 mg/dL. 1, 2, 3

Type 1 Diabetes Dosing

Initial Dosing

  • Total daily insulin requirement ranges from 0.4-1.0 units/kg/day, with 0.5 units/kg/day being the typical starting dose for metabolically stable patients 1, 2
  • Split the total daily dose equally: 50% as basal insulin and 50% as prandial insulin distributed across meals 1
  • Higher doses are required during puberty, pregnancy, and acute medical illness 1
  • Patients presenting with ketoacidosis require higher weight-based dosing initially 2

Administration Method

  • Multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII) are the preferred treatment approaches 1
  • Use rapid-acting insulin analogs (lispro, aspart, or glulisine) before meals to reduce hypoglycemia risk 1
  • CSII provides modest advantages with A1C reduction of -0.30% and reduced severe hypoglycemia rates compared to MDI 1

Prandial Insulin Adjustment

  • Educate patients to match prandial insulin doses to carbohydrate intake, premeal glucose levels, and anticipated physical activity 1
  • The carbohydrate-to-insulin ratio equals 300 divided by total daily dose at breakfast, or 400 divided by total daily dose at lunch and dinner 4

Type 2 Diabetes Dosing

Initial Basal Insulin Therapy

  • Start with 10 units once daily or 0.1-0.2 units/kg/day of long-acting basal insulin 1, 2, 3
  • Administer at the same time each day 2, 3
  • Continue metformin and other oral agents when initiating insulin 1, 2

Titration Protocol

  • Increase dose by 2-4 units every 3 days until fasting glucose reaches target of 80-130 mg/dL 1, 2
  • If fasting glucose ≥180 mg/dL, increase by 4 units every 3 days 2
  • If fasting glucose 140-179 mg/dL, increase by 2 units every 3 days 2
  • Alternative approach: increase by 10-15% or 2-4 units once or twice weekly 2

When to Add Prandial Insulin

  • When basal insulin exceeds 0.5 units/kg/day and A1C remains elevated despite controlled fasting glucose, add prandial insulin rather than continuing to escalate basal insulin 2
  • Start with 4 units of rapid-acting insulin before the largest meal, or 10% of the basal dose 1, 2
  • This prevents "overbasalization" which causes hypoglycemia and high glucose variability 2

High-Risk Patients

  • Use lower doses (0.1-0.25 units/kg/day) for elderly patients (>65 years), those with renal failure, or poor oral intake 1, 2

Hospitalized Patients

Critical Care Setting

  • Continuous intravenous insulin infusion is the preferred method for achieving glycemic targets in critically ill patients 1
  • Use validated written or computerized protocols for dose adjustments 1
  • Target glucose range of 140-180 mg/dL for most critically ill patients 1

Non-Critical Care Setting

  • For insulin-naive or low-dose patients, start with 0.3-0.5 units/kg/day total daily dose, with half as basal insulin 1, 2
  • For patients on high-dose home insulin (≥0.6 units/kg/day), reduce total daily dose by 20% to prevent hypoglycemia 2
  • Use basal-bolus regimen (basal insulin plus prandial insulin before meals) for patients with good nutritional intake 1
  • Use basal-plus-correction regimen for patients with poor oral intake or nothing by mouth 1
  • Sliding-scale insulin alone is strongly discouraged and should not be used 1

Transitioning from IV to Subcutaneous Insulin

  • Calculate subcutaneous dose from the average insulin infused during the 12 hours before transition 1
  • For a patient receiving 1.5 units/hour, the estimated daily dose is 36 units/24 hours 1
  • Give subcutaneous insulin 1-2 hours before discontinuing IV insulin 1
  • Convert to basal insulin at 60-80% of the daily infusion dose 1

Enteral/Parenteral Nutrition

  • For continuous tube feeding, calculate nutritional insulin as 1 unit per 10-15 grams of carbohydrate per day 1
  • For patients not previously on insulin, start with 5 units of NPH/detemir every 12 hours or 10 units of glargine every 24 hours 1, 2
  • For bolus enteral feedings, give 1 unit of regular or rapid-acting insulin per 10-15 grams of carbohydrate before each feeding 1

Glucocorticoid Therapy

  • For patients on once-daily morning steroids, use prandial insulin (often NPH) to cover daytime hyperglycemia 1
  • For long-acting glucocorticoids or continuous use, add 0.1-0.3 units/kg/day of glargine to the usual regimen 2

Critical Pitfalls to Avoid

  • Never use sliding-scale insulin alone in hospitalized patients with known diabetes 1
  • Do not continue escalating basal insulin beyond 0.5-1.0 units/kg/day without addressing postprandial hyperglycemia with prandial insulin 2
  • Avoid intramuscular injections, especially with long-acting insulins, as severe hypoglycemia may result 1
  • Do not inject into areas of lipodystrophy or localized cutaneous amyloidosis, as this causes erratic absorption 1, 3
  • Do not dilute or mix insulin glargine with any other insulin or solution 2, 3
  • Do not administer insulin glargine intravenously or via an insulin pump 3
  • Recognize that 75% of hypoglycemic episodes occur in patients using basal insulin, with peak incidence between midnight and 6:00 AM 1

Administration Technique

  • Inject subcutaneously into the abdominal area, thigh, or deltoid 3
  • Rotate injection sites within the same region to reduce lipodystrophy risk 3
  • Use the shortest needles (4-mm pen or 6-mm syringe needles) as first-line choice—they are safe, effective, and less painful 5
  • Visually inspect insulin for particulate matter and discoloration before administration 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

EADSG Guidelines: Insulin Therapy in Diabetes.

Diabetes therapy : research, treatment and education of diabetes and related disorders, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.